Thomas Gildea, MD

Appointed
2003

Education & Fellowships

Graduate School - Case Western Reserve University School of Medicine
Clinical Research
Cleveland, OH USA
2010

Fellowship - Cleveland Clinic
Pulmonary / Critical Care Medi
Cleveland, OH USA
2003

Residency - Yale-New Haven Hospital
Internal Medicine
New Haven, CT USA
2000

Medical Education - MCP Hahnemann University School of Medicine
Philadelphia, PA USA
1996

Undergraduate - University of Scranton
Biology
PA USA
1992

Additional Training

• Clinical Research Scholars Program, Case Western Reserve University, Masters in Clinical Research program

Professional Highlights

• Cleveland Clinic Innovator Award, 2006

Certifications

• Internal Medicine - Pulmonary Disease

Specialty Interests

Advanced diagnostic and therapeutic bronchoscopy, lung cancer

Awards & Honors

• D. Robert McCaffree, MD, Master FCCP Humanitarian Award
• Best Doctors in America, 2007-2016
• Physician Development Award, AlphaOne Foundation, 2006-2008
• Finalist, 2004 CHEST Foundation Best Poster in Category Award
• Clinical Research Award Finalist, American College of Chest Physicians, Chest Foundation, 2002

Innovations & Patents

• First physician in North America to perform electromagnetic navigation bronchoscopy
• NIH-NCAI Custom Airway
• Provisional Patents filed for Stent Manipulation Device

Memberships

• American Thoracic Society
• Fellow, American College of Chest Physicians
• American Association for Bronchology
• World Association for Bronchology
• Fellow, American College of Physicians

See publications for Thomas Gildea, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/1/2023, Dr. Gildea has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Gildea receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Intuitive Surgical, Inc.

Royalty Payments. Dr. Gildea receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• VisionAir Solutions, LLC, formerly NewCOS, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Gildea may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

• VisionAir Solutions, LLC, formerly NewCOS, Inc.

Equity Dr. Gildea owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

• VisionAir Solutions, LLC, formerly NewCOS, Inc.

Fiduciary Role. Dr. Gildea serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

• VisionAir Solutions, LLC, formerly NewCOS, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.